Inspire Medical Systems Financial Ratios
NYSE: INSPHealth CareMedical/Dental InstrumentsUSD
68.89+2.20 (+3.30%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Inspire Medical Systems ratio analysis
Inspire Medical Systems earned a net margin of 15.9% in FY 2025, up from 6.7% a year earlier. Gross margin was 85.4% compared with a median of 84.2% over the prior 8 years. Return on equity reached 18.6%, meaning Inspire Medical Systems generated 0.19 dollars of profit for every dollar of shareholders' equity.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Inspire Medical Systems financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 18.87 | 113.53 | — | — | — | — | — | — | — |
| Price / sales | 2.97 | 7.37 | 9.54 | 17.34 | 26.87 | 42.50 | 21.36 | 11.90 | — |
| Price / book | 3.47 | 8.57 | 10.41 | 14.26 | 27.38 | 21.35 | 12.53 | 3.67 | — |
| Gross margin | 85.4% | 84.7% | 84.5% | 83.8% | 85.7% | 84.7% | 83.4% | 80.1% | 78.9% |
| Operating margin | 5.6% | 4.5% | -6.4% | -11.7% | -17.1% | -48.7% | -42.5% | -40.3% | -56.0% |
| Net margin | 15.9% | 6.7% | -3.4% | -11.0% | -18.0% | -49.6% | -40.5% | -43.1% | -61.3% |
| Free cash flow margin | 8.6% | 11.4% | 0.2% | 0.6% | -10.6% | -48.1% | -43.4% | -37.4% | -56.7% |
| Return on equity (ROE) | 18.6% | 7.8% | -3.7% | -9.0% | -18.4% | -24.9% | -23.8% | -13.3% | -1,319.6% |
| Return on assets (ROA) | 16.0% | 6.6% | -3.1% | -7.9% | -14.2% | -20.3% | -18.3% | -10.9% | -69.8% |
| Debt / equity | — | — | — | 0.00 | 0.07 | 0.11 | 0.18 | 0.15 | 12.40 |
| Current ratio | 6.08 | 7.13 | 7.60 | 8.66 | 6.50 | 13.02 | 10.12 | 17.86 | 3.37 |
| Revenue growth | 13.6% | 28.5% | 53.2% | 74.7% | 102.3% | 40.6% | 62.2% | 77.1% | — |
| EPS growth | 179.4% | — | — | — | — | — | — | — | — |